Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimada

Showing results (301-310 of 360) with videos related to

Pageof 36
Sort By:
Pediatric Blood & Cancer|February 25, 2017
Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R studyHiroshi Moritake, Shiro Tanaka, Hideki Nakayama, et al.
Diabetology International|August 5, 2024
Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study, Takashi Murata, Yushi Hirota, et al.
British Journal of Haematology|February 21, 2019
Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakako Miyamura, Hiroshi Moritake, Hideki Nakayama, et al.
Genes, Chromosomes & Cancer|May 1, 2013
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaNorio Shiba, Hitoshi Ichikawa, Tomohiko Taki, et al.
Diabetes|July 31, 2009
Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetesShoichiro Tanaka, Yoriko Nishida, Kaoru Aida, et al.
British Journal of Haematology|November 30, 2011
Molecular lesions in childhood and adult acute megakaryoblastic leukaemiaAsahito Hama, Hideki Muramatsu, Hideki Makishima, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
Diabetology International|January 4, 2019
Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in JapanYoichi Oikawa, Akira Shimada, Takuya Awata, et al.
International Journal of Hematology|November 24, 2019
Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosisKazuko Kudo, Miho Maeda, Nobuhiro Suzuki, et al.
Pageof 36

Showing results (301-310 of 360) with videos related to

Sort By:
Pageof 36
Pediatric Blood & Cancer|February 25, 2017
Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R studyHiroshi Moritake, Shiro Tanaka, Hideki Nakayama, et al.
Diabetology International|August 5, 2024
Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study, Takashi Murata, Yushi Hirota, et al.
British Journal of Haematology|February 21, 2019
Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakako Miyamura, Hiroshi Moritake, Hideki Nakayama, et al.
Genes, Chromosomes & Cancer|May 1, 2013
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaNorio Shiba, Hitoshi Ichikawa, Tomohiko Taki, et al.
Diabetes|July 31, 2009
Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetesShoichiro Tanaka, Yoriko Nishida, Kaoru Aida, et al.
British Journal of Haematology|November 30, 2011
Molecular lesions in childhood and adult acute megakaryoblastic leukaemiaAsahito Hama, Hideki Muramatsu, Hideki Makishima, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
Diabetology International|January 4, 2019
Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in JapanYoichi Oikawa, Akira Shimada, Takuya Awata, et al.
International Journal of Hematology|November 24, 2019
Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosisKazuko Kudo, Miho Maeda, Nobuhiro Suzuki, et al.
Pageof 36